Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

29.00
BATS BZX Real-Time Price
As of 11:31am ET
 +0.16 / +0.55%
Today’s Change
27.62
Today|||52-Week Range
51.42
-32.18%
Year-to-Date
Teva Inches Closer to Completion of Allergan Generics Deal
Jun 28 / TheStreet.com - Paid Partner Content
Why Impax Laboratories, Werner Enterprises, and Planet Fitness Slumped Today
Jun 21 / MotleyFool.com - Paid Partner Content
Impax (IPXL) Stock Declines on Deal to Buy Generic Products
Jun 22 / Zacks.com - Paid Partner Content
Why Is Impax Labs Tumbling 11.7% Today
Jun 21 / MotleyFool.com - Paid Partner Content
Impax Laboratories (IPXL) Marked As A Dead Cat Bounce Stock
Jun 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close28.84
Today’s open28.66
Day’s range28.54 - 29.16
Volume12,376
Average volume (3 months)724,054
Market cap$2.1B
Dividend yield--
Data as of 11:31am ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+21.89%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+44.36%
P/E ratio60.0
Price/Sales3.58
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc+1.34+4.53%
GLPGGalapagos NV+1.45+2.76%
GWPHGW Pharmaceuticals P...+1.49+1.62%
RAREUltragenyx Pharmaceu...-1.22-2.40%
Data as of 11:32am ET, 06/29/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.36
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

Partner Offers

Search for Jobs